JW Biotech "Recent Embezzlement and Breach of Trust Disclosure Unrelated to Current Management"
[Asia Economy Reporter Jang Hyowon] Biotechnology specialist company GW Biotech (CEO Yang Jaewon) announced on the 19th that the ‘progress on embezzlement and breach of trust charges’ disclosed on the 18th is a disclosure made in accordance with regulations regarding a past lawsuit and is unrelated to current management.
A company official stated, “The embezzlement and breach of trust case occurred in October 2020, during a period when trading was suspended due to a refusal of audit opinion,” and added, “After a comprehensive review including the embezzlement and breach of trust case, all regulations were met and trading resumed, so it is unrelated to current management and there is no need to worry.”
Hot Picks Today
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- "To Get Revenge on Ex-Girlfriend" US McDonald's Manager Spits on French Fries
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
He further explained, “An appeal trial is scheduled to proceed due to the opposing party’s appeal,” and added, “Once the court ruling is finalized, procedures to recover the embezzled and breached amount of 18.3 billion KRW will be carried out.”
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.